000 03571nam a22005415i 4500
001 978-1-0716-0838-8
003 DE-He213
005 20260610083631.0
007 cr nn 008mamaa
008 201119s2021 xxu| s |||| 0|eng d
020 _a9781071608388
_9978-1-0716-0838-8
024 7 _a10.1007/978-1-0716-0838-8
_2doi
050 4 _aRC321-580
072 7 _aPSAN
_2bicssc
072 7 _aSCI089000
_2bisacsh
072 7 _aPSAN
_2thema
082 0 4 _a612.8
_223
245 1 0 _aNanomedicines for Brain Drug Delivery
_h[electronic resource] /
_cedited by Javier O. Morales, Pieter J. Gaillard.
250 _a1st ed. 2021.
264 1 _aNew York, NY :
_bSpringer US :
_bImprint: Humana,
_c2021.
300 _aXII, 280 p. 33 illus., 27 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aNeuromethods,
_x1940-6045 ;
_v157
505 0 _aBiodegradable Polymeric Nanoparticles for Brain-Targeted Drug Delivery -- Liposomes as Brain Targeted Delivery Systems -- Nanofibres and Nanostructured Scaffolds for Nervous System Lesions -- Self-Assembling Peptide Nanofibrous Scaffolds in Central Nervous System Lesions -- The Use of Peptide and Protein Vectors to Cross the Blood Brain Barrier for the Delivery of Therapeutic Concentration of Biologics -- Inorganic Nanoparticles and Their Strategies to Enhance Brain Drug Delivery -- Magnetic Nanoparticles as Delivery Systems to Penetrate the Blood Brain Barrier -- Nose-to-Brain Drug Delivery Enabled by Nanocarriers -- In Vitro Models of Central Nervous System Barriers for Blood Brain Barrier Permeation Studies -- Safety and Nanotoxicity Aspects of Nanomedicines for Brain-Targeted Drug Delivery.
520 _aThis volume explores the latest research in central nervous system (CNS) targeted nanocarriers, methods for their synthesis, and its characterization process. Chapters in this book cover topics such as polymeric nanoparticles and liposomes; self-assembled peptide-based scaffolds for lesions of the nervous system; use of peptides as CNS drugs and as potential carriers to optimize brain-targeted delivery; ways to model and assess blood brain barrier absorption of drugs; and the role of neurodegeneration progress of nanomaterials and their potential toxicity concerns. In the Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Thorough and cutting-edge, Nanomedicines for Brain Drug Delivery is a valuable resource that will help researchers guide and advance the field of nanomedicines for the brain and nervous system.
650 0 _aNeurosciences.
650 0 _aBiomaterials.
650 0 _aBiotechnology.
650 0 _aPharmacology.
650 1 4 _aNeuroscience.
650 2 4 _aBiomaterials.
650 2 4 _aBiotechnology.
650 2 4 _aPharmacology.
700 1 _aMorales, Javier O.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aGaillard, Pieter J.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9781071608371
776 0 8 _iPrinted edition:
_z9781071608395
776 0 8 _iPrinted edition:
_z9781071608401
830 0 _aNeuromethods,
_x1940-6045 ;
_v157
856 4 0 _uhttps://doi.org/10.1007/978-1-0716-0838-8
912 _aZDB-2-PRO
999 _c5540
_d5540